The Week Ahead: COS...
Health Care: Drugs
Amarin Corporation PLC (AMRN: NASDAQ)
$6.78 -0.14 | -2.02%
05/24/13 - 04:00 PM ET
Portfolios with AMRN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- Useralexr685
- ContributorDrugs Facing FDA Approval i...
- ContributorHigh Volume Technicals for ...
- ContributorBreakout Stocks Of The Week...
- UserHassan Portfolio
- Contributor4 Drug Stocks Facing FDA Ap...
- UserLividog
- ContributorStocks Rising On Unusual Vo...
- UserPharma
Latest AMRN Headlines from TheStreet
- Biotech Stock Mailbag: Amarin, MannKind, Palatin 05.24.13 | 07:05 am
- Amarin Announces Notification Of Patent Allowance For U.S. Application 13/417,899 Related To Combination Product Of Vascepa(R) And Statin Therapy 05.22.13 | 06:05 am
- Why Keryx is Lagging But Acadia is Zooming (Hint: It's About NCE) 05.21.13 | 10:05 am
- 2013 FDA Drug Approval Calendar 05.21.13 | 07:05 am
- Biotech Stock Mailbag: Synta, Zogenix, Sarepta, Amarin 05.10.13 | 07:05 am
- Photo Release -- Amarin Reports First Quarter 2013 Financial Results And Provides Update On Operations 05.09.13 | 04:05 pm
- Amarin Trouble Grows As Does Evidence Against Fish Oil's Benefits 05.09.13 | 12:05 am
- Amarin To Report First Quarter 2013 Results And Host Conference Call On May 9, 2013 05.03.13 | 04:05 pm
- Amarin Announces Approval Of Supplemental New Drug Application For BASF As Additional Vascepa(R) Active Pharmaceutical Ingredient Supplier 04.30.13 | 06:04 am
- Biotech Stock Mailbag: ASCO, Sarepta, Cel-Sci and Hate Mail! 04.26.13 | 08:04 am
Press Releases for AMRN
- Amarin To Present At The Deutsche Bank 26th Annual Healthcare Conference - PR Newswire 04.26.11 | 08:04 am
- Amarin's AMR101 Phase 3 ANCHOR Trial Meets All Primary And Secondary Endpoints With Statistically Significant Reductions In Triglycerides At Both 4 Gram And 2 Gram Doses And Statistically Significant Decrease In LDL-C - PR Newswire 04.18.11 | 02:04 am
- Phase 3 MARINE Trial Data To Be Presented In May At The National Lipid Association 2011 Annual Scientific Sessions - PR Newswire 04.05.11 | 08:04 am
- Amarin To Present At The 10th Annual Needham Healthcare Conference - PR Newswire 03.31.11 | 07:03 am
Partner Headlines for AMRN
- Will Amarin’s Positive Test Result Impress These Top Institutional Shareholders? - Wall St. Cheat Sheet 04.08.13 | 01:04 pm
- Will Amarin’s Positive Test Result Impress These Top Institutional Shareholders? - Wall St. Cheat Sheet 04.08.13 | 01:04 pm
- 4 Healthcare Stock Stories for Monday Investment Wellness - Wall St. Cheat Sheet 04.01.13 | 02:04 am
- 4 Healthcare Stock Stories for Monday Investment Wellness - Wall St. Cheat Sheet 04.01.13 | 02:04 am
- Trius Therapeutics: New MSRA Treatment Could Bring Billions In Revenues - Seeking Alpha 03.05.13 | 09:03 am
- Stock Watch Tuesday, 8 January - Seeking Alpha 01.08.13 | 09:01 am
- Stock Watch Wednesday, 2 January - Seeking Alpha 01.02.13 | 08:01 am
- 5 Medical Stock Losers From Last Week With High Short Ratios - Seeking Alpha 12.22.12 | 06:12 am
- Pre-Market Most Active for Dec 7, 2012 : BAC, QQQ, NOK, AMRN, VNTV, AVGO, MEMP, AAPL, FB, SAN, C, FCX - NASDAQ 12.07.12 | 01:12 pm
- After Hours Most Active for Dec 6, 2012 : MMR, BX, QQQ, S, AMRN, EPHC, BAC, EMC, AIG, DISH, LINTA, ORCL - NASDAQ 12.06.12 | 09:12 pm
